Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Baldrick

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Expert Opinion on Pharmacotherapy|January 20, 2025
Juvenile animal studies in human drug developmentPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|July 31, 2013
The evolution of juvenile animal testing for small and large moleculesPaul Baldrick
Therapeutic Innovation & Regulatory Science|December 10, 2020
Nonclinical Immunotoxicity Testing in the Pharmaceutical World: The Past, Present, and FuturePaul Baldrick
Therapeutic Innovation & Regulatory Science|May 2, 2018
Juvenile Animal Testing: Assessing Need and Use in the Drug Product LabelPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|April 24, 2017
Pharmacokinetic and toxicology comparator testing of biosimilar drugs - Assessing needPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|June 15, 2014
Utility and importance of animal data in drug product labelsPaul Baldrick
Journal of Pharmacological and Toxicological Methods|April 4, 2021
Core battery safety pharmacology testing - An assessment of its utility in early drug developmentPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|May 12, 2004
Developing drugs for pediatric use: a role for juvenile animal studies?Paul Baldrick
Therapeutic Innovation & Regulatory Science|August 15, 2019
Nonclinical Immunotoxicity Testing in the Pharmaceutical World: The Past, Present, and FuturePaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|May 24, 2022
Development of COVID-19 therapies: Nonclinical testing considerationsPaul Baldrick
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Expert Opinion on Pharmacotherapy|January 20, 2025
Juvenile animal studies in human drug developmentPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|July 31, 2013
The evolution of juvenile animal testing for small and large moleculesPaul Baldrick
Therapeutic Innovation & Regulatory Science|December 10, 2020
Nonclinical Immunotoxicity Testing in the Pharmaceutical World: The Past, Present, and FuturePaul Baldrick
Therapeutic Innovation & Regulatory Science|May 2, 2018
Juvenile Animal Testing: Assessing Need and Use in the Drug Product LabelPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|April 24, 2017
Pharmacokinetic and toxicology comparator testing of biosimilar drugs - Assessing needPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|June 15, 2014
Utility and importance of animal data in drug product labelsPaul Baldrick
Journal of Pharmacological and Toxicological Methods|April 4, 2021
Core battery safety pharmacology testing - An assessment of its utility in early drug developmentPaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|May 12, 2004
Developing drugs for pediatric use: a role for juvenile animal studies?Paul Baldrick
Therapeutic Innovation & Regulatory Science|August 15, 2019
Nonclinical Immunotoxicity Testing in the Pharmaceutical World: The Past, Present, and FuturePaul Baldrick
Regulatory Toxicology and Pharmacology : RTP|May 24, 2022
Development of COVID-19 therapies: Nonclinical testing considerationsPaul Baldrick
Pageof 6